From: Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012
Characteristics, n % | HBV, nā=ā57,929 | HCV, nā=ā92,474 | ||||||
---|---|---|---|---|---|---|---|---|
Alive | Ā | Deceaseda | Ā | Alive | Ā | Deceaseda | Ā | |
nā=ā55,147 | % | nā=ā2782 | % | nā=ā83,267 | % | nā=ā9207 | % | |
Birth cohortb | ||||||||
āā„ā1965 | 31,000 | 56 | 423 | 15 | 43,919 | 53 | 2253 | 24 |
ā1945-1964 | 20,595 | 37 | 1166 | 42 | 35,964 | 43 | 4795 | 52 |
āā¤ā1944 | 3541 | 6 | 1193 | 43 | 3359 | 4 | 2159 | 23 |
Male genderb | 29,949 | 55 | 2074 | 75 | 51,062 | 62 | 6507 | 71 |
Country of birthb | ||||||||
āAustralia | 5406 | 20 | 546 | 30 | 34,263 | 78 | 4030 | 71 |
āAsia-Pacific | 16,692 | 63 | 817 | 45 | 4037 | 9 | 490 | 9 |
āMiddle East and North Africa | 2029 | 8 | 85 | 5 | 1263 | 3 | 198 | 4 |
āAfrica, excluding North Africa | 577 | 2 | 14 | 1 | 191 | <ā1 | 15 | <ā1 |
āEurope | 1782 | 7 | 322 | 18 | 3512 | 8 | 884 | 16 |
āAmericas | 134 | 1 | 11 | 1 | 415 | 1 | 39 | 1 |
Year of viral hepatitis notification | ||||||||
āā¤ā2000 | 24,696 | 45 | 1634 | 59 | 43,067 | 52 | 6014 | 65 |
ā2001-2006 | 16,514 | 30 | 782 | 28 | 23,250 | 28 | 2229 | 24 |
ā2007-2012 | 13,937 | 25 | 366 | 13 | 16,950 | 20 | 964 | 10 |
HBV/HCV co-infectionc | 3232 | 6 | 480 | 17 | ā | ā | ā | ā |
HIV co-infection | 276 | 1 | 72 | 3 | 812 | 1 | 153 | 2 |
HBV/HCV/HIV co-infectionc | 50 | <ā1 | 14 | <ā1 | ā | ā | ā | ā |
Area of residence at the time of viral hepatitis notificationb,d | ||||||||
āRural | 5342 | 10 | 440 | 16 | 28,610 | 35 | 2963 | 32 |
āOuter metropolitan | 25,068 | 46 | 1245 | 45 | 26,608 | 33 | 3167 | 35 |
āMetropolitan | 24,183 | 44 | 1082 | 39 | 26,331 | 32 | 3025 | 33 |
History of alcohol-use disorder | 1566 | 3 | 374 | 13 | 12,855 | 15 | 2652 | 29 |
History of OST | 1442 | 3 | 225 | 8 | 24,427 | 29 | 2813 | 31 |